Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
Overcoming Obstacles in AAV Viral Vector Manufacturing
Endotoxin Control Strategies for Parenteral Drug Product Manufacturing
Robert Simler Associate Director, Engineering and Technology Biogen, Cambridge, MA, USA
Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies
James Barry, Director of Marketing, Americas, Pall Biotech
View All Featured ArticlesHeadline News
Gilead expands access plans for investigational Ebola antiviral obeldesivir
Thermo Fisher launches Gibco VaxEvo medium for adenovirus vaccine production
Abbott begins VOYAGER trial of investigational Encantor TAVI system
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release
Presented by Jeff Doyle & Dr Paul Jeffers, Pfizer. Followed by Jonas Elfving, MKS
07th February 2017
Vaccine Development & its Manufacturing using Integrated High Throughput Technology
Presented by Dr. S.K. Jana, Director - R&D and Manufacturing, Human Vaccine Development, Serum Institute of India Pvt. Ltd. and Vikas Revankar, Head of Product Management and Marketing - Digital Portfolio, BioContinuum™ Platform - Merck and Piergiuseppe Nestola, PhD Global Vaccine Technology Consultant at Sartorius
20th September 2021
New Tools to Assess the Risk of Microbial Impurities in the Pharmaceutical Manufacturing Process
Presented by Dr Friedrich von Wintzingerode, Senior Manager, Global Analytical Science & Technology (gASAT) Microbiology, Global QC bei Roche and Mathilde Arnault, Research Scientist, BioMonitoring R&D, Merck KGaA, Darmstadt, Germany
09th April 2019
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Best Practices for Achieving Virus Safety
Strategy Emerging Markets for Risk Mitigation
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















